Neil Abdollahian - 27 Mar 2024 Form 3 Insider Report for Boundless Bio, Inc. (BOLD)

Role
Chief Business Officer
Signature
/s/ Jessica Oien, Attorney-in-Fact for Neil Abdollahian
Issuer symbol
BOLD
Transactions as of
27 Mar 2024
Net transactions value
$0
Form type
3
Filing time
27 Mar 2024, 20:16:39 UTC
Next filing
20 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BOLD Stock Option 27 Mar 2024 Common Stock 82,051 $4.10 Direct F1
holding BOLD Stock Option 27 Mar 2024 Common Stock 19,948 $4.10 Direct F2
holding BOLD Stock Option 27 Mar 2024 Common Stock 54,871 $4.10 Direct F3
holding BOLD Stock Option 27 Mar 2024 Common Stock 36,852 $8.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on August 9, 2022, and vests as to the remaining underlying shares in 48 substantially equal monthly installments thereafter.
F2 The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.
F3 The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.
F4 The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

Remarks:

Exhibit 24 - Power of Attorney.